JPH0524900B2 - - Google Patents
Info
- Publication number
- JPH0524900B2 JPH0524900B2 JP60038943A JP3894385A JPH0524900B2 JP H0524900 B2 JPH0524900 B2 JP H0524900B2 JP 60038943 A JP60038943 A JP 60038943A JP 3894385 A JP3894385 A JP 3894385A JP H0524900 B2 JPH0524900 B2 JP H0524900B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- methoxyphenyl
- aryl
- hydroxypropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- HPVXSACNADIMIQ-FQEVSTJZSA-N 1-[(2s)-3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropyl]-2-(4-methoxyphenyl)-6-methylpyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1C1=NC(=O)C=C(C)N1C[C@@H](O)CNCCC1=CC=C(OC)C(OC)=C1 HPVXSACNADIMIQ-FQEVSTJZSA-N 0.000 claims 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 2
- UBRDHFHLTKXRQF-IBGZPJMESA-N 5-chloro-1-[(2s)-3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropyl]-2-(4-methoxyphenyl)-6-methylpyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1C1=NC(=O)C(Cl)=C(C)N1C[C@@H](O)CNCCC1=CC=C(OC)C(OC)=C1 UBRDHFHLTKXRQF-IBGZPJMESA-N 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 238000010992 reflux Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- -1 H 2 SO 4 Chemical class 0.000 description 5
- 239000002876 beta blocker Substances 0.000 description 5
- 125000001309 chloro group Chemical group Cl* 0.000 description 5
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002220 antihypertensive agent Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- CSISQILZUHMAJB-UHFFFAOYSA-N 4-methoxybenzenecarboximidamide Chemical compound COC1=CC=C(C(N)=N)C=C1 CSISQILZUHMAJB-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 230000003288 anthiarrhythmic effect Effects 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 239000003416 antiarrhythmic agent Substances 0.000 description 3
- 229940030611 beta-adrenergic blocking agent Drugs 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 3
- 230000003293 cardioprotective effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- ZCKGUNLVPWUALG-IBGZPJMESA-N (2s)-1-[5-chloro-2-(4-methoxyphenyl)-6-methylpyrimidin-4-yl]oxy-3-[2-(3,4-dimethoxyphenyl)ethylamino]propan-2-ol Chemical compound C1=CC(OC)=CC=C1C1=NC(C)=C(Cl)C(OC[C@@H](O)CNCCC=2C=C(OC)C(OC)=CC=2)=N1 ZCKGUNLVPWUALG-IBGZPJMESA-N 0.000 description 2
- BNIIDNLZJNRHAV-RSAXXLAASA-N 1-[(2s)-2-hydroxy-3-(propan-2-ylamino)propyl]-2-(4-methoxyphenyl)-6-methylpyrimidin-4-one;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1C1=NC(=O)C=C(C)N1C[C@@H](O)CNC(C)C BNIIDNLZJNRHAV-RSAXXLAASA-N 0.000 description 2
- BEZVVXXSXXEMFA-UHFFFAOYSA-N 2-(4-methoxyphenyl)-1h-pyrimidin-6-one Chemical compound C1=CC(OC)=CC=C1C1=NC=CC(=O)N1 BEZVVXXSXXEMFA-UHFFFAOYSA-N 0.000 description 2
- YIDRCIOAPLVRFZ-UHFFFAOYSA-N 2-methyl-6-phenyl-1h-pyrimidin-4-one Chemical compound N1C(C)=NC(=O)C=C1C1=CC=CC=C1 YIDRCIOAPLVRFZ-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- LYRRLOIXAPNHFQ-FYZYNONXSA-N 5-chloro-1-[(2s)-3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropyl]-2-(4-methoxyphenyl)-6-methylpyrimidin-4-one;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1C1=NC(=O)C(Cl)=C(C)N1C[C@@H](O)CNCCC1=CC=C(OC)C(OC)=C1 LYRRLOIXAPNHFQ-FYZYNONXSA-N 0.000 description 2
- YHBRJAVOZSMFIS-UHFFFAOYSA-N 5-chloro-2,4-diphenylpyrimidine Chemical compound ClC1=CN=C(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 YHBRJAVOZSMFIS-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000004004 anti-anginal agent Substances 0.000 description 2
- 229940124345 antianginal agent Drugs 0.000 description 2
- 229940030600 antihypertensive agent Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000012659 cardioprotective agent Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- BEBCNKRBQDWJAW-QHCPKHFHSA-N (2s)-1-(5-chloro-2,6-diphenylpyrimidin-4-yl)oxy-3-[2-(3,4-dimethoxyphenyl)ethylamino]propan-2-ol Chemical compound C1=C(OC)C(OC)=CC=C1CCNC[C@H](O)COC1=NC(C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=C1Cl BEBCNKRBQDWJAW-QHCPKHFHSA-N 0.000 description 1
- KHONNCJQOKUODW-IBGZPJMESA-N (2s)-1-(5-chloro-2-methyl-6-phenylpyrimidin-4-yl)oxy-3-[2-(3,4-dimethoxyphenyl)ethylamino]propan-2-ol Chemical compound C1=C(OC)C(OC)=CC=C1CCNC[C@H](O)COC1=NC(C)=NC(C=2C=CC=CC=2)=C1Cl KHONNCJQOKUODW-IBGZPJMESA-N 0.000 description 1
- FXAQNYPURSUREG-KRWDZBQOSA-N 1-[(2s)-3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropyl]-2,5,6-trimethylpyrimidin-4-one Chemical compound C1=C(OC)C(OC)=CC=C1CCNC[C@H](O)CN1C(C)=C(C)C(=O)N=C1C FXAQNYPURSUREG-KRWDZBQOSA-N 0.000 description 1
- NRDLXJASWYBSPY-DEOSSOPVSA-N 1-[(2s)-3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropyl]-2,6-diphenylpyrimidin-4-one Chemical compound C1=C(OC)C(OC)=CC=C1CCNC[C@H](O)CN1C(C=2C=CC=CC=2)=NC(=O)C=C1C1=CC=CC=C1 NRDLXJASWYBSPY-DEOSSOPVSA-N 0.000 description 1
- RRTJSVATZVUBHQ-BDQAORGHSA-N 1-[(2s)-3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropyl]-2-(4-methoxyphenyl)-6-methylpyrimidin-4-one;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1C1=NC(=O)C=C(C)N1C[C@@H](O)CNCCC1=CC=C(OC)C(OC)=C1 RRTJSVATZVUBHQ-BDQAORGHSA-N 0.000 description 1
- XWXLKWUBCZTEGY-FQEVSTJZSA-N 1-[(2s)-3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropyl]-6-methyl-2-phenylpyrimidin-4-one Chemical compound C1=C(OC)C(OC)=CC=C1CCNC[C@H](O)CN1C(C=2C=CC=CC=2)=NC(=O)C=C1C XWXLKWUBCZTEGY-FQEVSTJZSA-N 0.000 description 1
- BIXKUCQZIIOIEC-UHFFFAOYSA-N 2,5,6-trimethyl-1h-pyrimidin-4-one Chemical compound CC1=NC(C)=C(C)C(O)=N1 BIXKUCQZIIOIEC-UHFFFAOYSA-N 0.000 description 1
- XRSLJJMPKREAES-UHFFFAOYSA-N 2,6-diphenyl-1h-pyrimidin-4-one Chemical group N=1C(O)=CC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 XRSLJJMPKREAES-UHFFFAOYSA-N 0.000 description 1
- WYVODXRUKCGYFX-UHFFFAOYSA-N 2-(4-methoxyphenyl)-6-methyl-1h-pyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1C1=NC(=O)C=C(C)N1 WYVODXRUKCGYFX-UHFFFAOYSA-N 0.000 description 1
- JJXBLRJIMBFLMY-UHFFFAOYSA-N 2-phenyl-1h-pyrimidin-6-one Chemical compound OC1=CC=NC(C=2C=CC=CC=2)=N1 JJXBLRJIMBFLMY-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- FQJLWJLEEAJORU-UHFFFAOYSA-N 4,5-dichloro-2-(4-methoxyphenyl)-6-methylpyrimidine Chemical compound C1=CC(OC)=CC=C1C1=NC(C)=C(Cl)C(Cl)=N1 FQJLWJLEEAJORU-UHFFFAOYSA-N 0.000 description 1
- DBPKMSBWOKAKLA-UHFFFAOYSA-N 4-chloropyrimidine Chemical compound ClC1=CC=NC=N1 DBPKMSBWOKAKLA-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- QOXQEDOEGYHLQY-UHFFFAOYSA-N 4-methylbenzenesulfonic acid;1,3-oxazolidine Chemical compound C1COCN1.CC1=CC=C(S(O)(=O)=O)C=C1 QOXQEDOEGYHLQY-UHFFFAOYSA-N 0.000 description 1
- HWSLWZDDTJNMMC-UHFFFAOYSA-N 5-chloro-2-(4-methoxyphenyl)-6-methyl-1h-pyrimidin-4-one Chemical group C1=CC(OC)=CC=C1C1=NC(C)=C(Cl)C(=O)N1 HWSLWZDDTJNMMC-UHFFFAOYSA-N 0.000 description 1
- LANLQHJVBKIMDD-UHFFFAOYSA-N 5-chloro-2-methyl-4-phenylpyrimidine Chemical compound CC1=NC=C(Cl)C(C=2C=CC=CC=2)=N1 LANLQHJVBKIMDD-UHFFFAOYSA-N 0.000 description 1
- BQXCSFIZYMLIAU-UHFFFAOYSA-N 6-methyl-2-phenyl-1h-pyrimidin-4-one Chemical compound N1C(C)=CC(=O)N=C1C1=CC=CC=C1 BQXCSFIZYMLIAU-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- INQQYSCYRVAEDE-SSHVMLJWSA-N O.Cl.COC=1C=C(C=CC1OC)CCNC[C@@H](CN1C(=NC(C=C1C)=O)C1=CC=C(C=C1)OC)O.O.O.COC=1C=C(C=CC1OC)CCNC[C@@H](CN1C(=NC(C=C1C)=O)C1=CC=C(C=C1)OC)O.Cl Chemical compound O.Cl.COC=1C=C(C=CC1OC)CCNC[C@@H](CN1C(=NC(C=C1C)=O)C1=CC=C(C=C1)OC)O.O.O.COC=1C=C(C=CC1OC)CCNC[C@@H](CN1C(=NC(C=C1C)=O)C1=CC=C(C=C1)OC)O.Cl INQQYSCYRVAEDE-SSHVMLJWSA-N 0.000 description 1
- 229910019213 POCl3 Inorganic materials 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 230000003257 anti-anginal effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 102000015005 beta-adrenergic receptor activity proteins Human genes 0.000 description 1
- 108040006818 beta-adrenergic receptor activity proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000007883 bronchodilation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- NTDIQJHXDJAOHF-UHFFFAOYSA-N methanesulfonic acid;1,3-oxazolidin-2-one Chemical compound CS(O)(=O)=O.O=C1NCCO1 NTDIQJHXDJAOHF-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000004002 naphthaldehydes Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
æ¬çºæã¯ãæ§é åŒïŒ
ã§ç€ºãããæ°èŠååç©ã«é¢ãããã®ã§ããã
åŒäžïŒ²ã¯
ãåŒããŸãã¯
ãåŒã
ã§ãããR1ïŒR2ïŒR3ããã³R4ã¯åŸã«å®çŸ©ããã
éãã§ããã ãããã®æ°èŠãªååç©ããã³ãããã®å»è¬çã«
䜿çšãåŸãå¡©ã¯ãβ2âã¢ãã¬ããªã³å容äœã«çŽæ¥
åŒç·©äœçšãæããå¿èéžæβâã¢ãã¬ããªã³é®æ
掻æ§ã瀺ããæé«è¡å§ãå¿èä¿è·ãæäžæŽèãã
ã³æã¢ã³ã®ãå€ãšããŠæçšã§ããã å¿èãè¡ç®¡ããã³èºæ©èœã«åœ±é¿ãåãŒããç·©å
ãªæé«è¡å§å€ã§ããβâã¢ãã¬ããªã³é®æå€ãšã
ãŠç¥ãããäžçŸ€ã®å»è¬å€ãå©çšãããŠãããç¹ã«
ãããã®è¬å€ã¯è¡ç®¡éåæå¶ãæ®æããããŸãã¯
æ°ç®¡æ¯æ¡åŒµãæå¶ããã«å¿å床æ°ãäœäžãããèœ
åãæãããβâã¢ãã¬ããªã³é®æå€ããããã®
ååŠæ§é ããã³äœçšã¯ãã¯ãªãã«ã«ãã¢ãŒãã³ã
ãžãŒã¢ã³ãã»ã©ãã€ãã€ãã¯ã¹ã第10å·»ã第292
ã306é ïŒ1969幎ïŒã«é瀺ããããçš®ã ã®Î²âã¢
ãã¬ããªã³é®æå€ããŸã次ã®ç¹èš±ã«èšèŒãããã
ç±³åœç¹èš±ç¬¬3048387å·ãå第3337628å·ãå第
3655663å·ãå第3794650å·ãå第3832470å·ãå
第3836666å·ãå第3850945å·ãå第3850946å·ã
å第3850947å·ãå第3852291å·ãå第4134983å·ã
å第4199580å·ãå第4115575å·ãå第4195090å·ã
è±åœç¹èš±ç¬¬1194548å·ãããã³åã¢ããªã«ç¹èš±ç¬¬7
ïŒïŒïŒïŒïŒïŒå·ã ããã§ãæ¬æ现æžã§ã¯ãæ°èŠãªå¿èéžæβâé®
æå€ããããã®åææ¹æ³ãæ°èŠãªååç©ã®ïŒçš®ãŸ
ãã¯ãã以äžãå å«ããŠããé®æåŠæ¹ããã³æé«
è¡å§ãå¿èä¿è·ãæäžæŽèãŸãã¯æã¢ã³ã®ãå€ã
瀺ãæ°èŠãªååç©ãŸãã¯ãã®å»è¬çµæç©ã§ã®æ²»ç
æ¹æ³ãæäŸãããã®ã§ããã æ¬çºæã®æ°èŠãªååç©ã¯ãæ§é åŒïŒ ãŸãã¯ãã®å»è¬çã«äœ¿çšãåŸãå¡©ãåŒäžïŒ²ã¯
éãã§ããã ãããã®æ°èŠãªååç©ããã³ãããã®å»è¬çã«
䜿çšãåŸãå¡©ã¯ãβ2âã¢ãã¬ããªã³å容äœã«çŽæ¥
åŒç·©äœçšãæããå¿èéžæβâã¢ãã¬ããªã³é®æ
掻æ§ã瀺ããæé«è¡å§ãå¿èä¿è·ãæäžæŽèãã
ã³æã¢ã³ã®ãå€ãšããŠæçšã§ããã å¿èãè¡ç®¡ããã³èºæ©èœã«åœ±é¿ãåãŒããç·©å
ãªæé«è¡å§å€ã§ããβâã¢ãã¬ããªã³é®æå€ãšã
ãŠç¥ãããäžçŸ€ã®å»è¬å€ãå©çšãããŠãããç¹ã«
ãããã®è¬å€ã¯è¡ç®¡éåæå¶ãæ®æããããŸãã¯
æ°ç®¡æ¯æ¡åŒµãæå¶ããã«å¿å床æ°ãäœäžãããèœ
åãæãããβâã¢ãã¬ããªã³é®æå€ããããã®
ååŠæ§é ããã³äœçšã¯ãã¯ãªãã«ã«ãã¢ãŒãã³ã
ãžãŒã¢ã³ãã»ã©ãã€ãã€ãã¯ã¹ã第10å·»ã第292
ã306é ïŒ1969幎ïŒã«é瀺ããããçš®ã ã®Î²âã¢
ãã¬ããªã³é®æå€ããŸã次ã®ç¹èš±ã«èšèŒãããã
ç±³åœç¹èš±ç¬¬3048387å·ãå第3337628å·ãå第
3655663å·ãå第3794650å·ãå第3832470å·ãå
第3836666å·ãå第3850945å·ãå第3850946å·ã
å第3850947å·ãå第3852291å·ãå第4134983å·ã
å第4199580å·ãå第4115575å·ãå第4195090å·ã
è±åœç¹èš±ç¬¬1194548å·ãããã³åã¢ããªã«ç¹èš±ç¬¬7
ïŒïŒïŒïŒïŒïŒå·ã ããã§ãæ¬æ现æžã§ã¯ãæ°èŠãªå¿èéžæβâé®
æå€ããããã®åææ¹æ³ãæ°èŠãªååç©ã®ïŒçš®ãŸ
ãã¯ãã以äžãå å«ããŠããé®æåŠæ¹ããã³æé«
è¡å§ãå¿èä¿è·ãæäžæŽèãŸãã¯æã¢ã³ã®ãå€ã
瀺ãæ°èŠãªååç©ãŸãã¯ãã®å»è¬çµæç©ã§ã®æ²»ç
æ¹æ³ãæäŸãããã®ã§ããã æ¬çºæã®æ°èŠãªååç©ã¯ãæ§é åŒïŒ ãŸãã¯ãã®å»è¬çã«äœ¿çšãåŸãå¡©ãåŒäžïŒ²ã¯
ãåŒããŸãã¯
ãåŒã
ã§ããã
R1ããã³R2ã¯ç¬ç«ã«
ïŒ æ°ŽçŽ ã
ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã
ïŒ çœ®æãããªããŸãã¯
ïœã¯ããããã«ãªããŸãã¯ããã¢ã®ãããªã
ãã ïœ C1-3ã¢ã«ã³ãã·ãŸãã¯ ïœ C1-3ã¢ã«ãã« ããéžæãããïŒãïŒåã®çœ®æåºã§çœ®æãã
ãããšãã«ãŸãã¯ãããã«ã®ãããªççŽ ç°ã¢ãª
ãŒã«ã ïŒ ããªãžãã«ããã©ãžãã«ãããªããžãã«ãã
ãšãã«ãããªã«ãâã¡ãã«ããªã«ãªã©ã®ãã
ãªïŒãŸãã¯ïŒå¡ã®è€çŽ ç°ã¢ãªãŒã«ïŒå°ãªããšã
ïŒå¡ãççŽ ã§ããããããååã¯ïŒ¯ïŒïŒ®ãŸãã¯
ã§ããïŒã§ããã R3ã¯ïŒ æ°ŽçŽ ã ïŒ ãã«ãªããã¯ãããŸãã¯ããã¢ã奜ãŸããã¯
ãã«ãªããŸãã¯ã¯ããã®ãããªããã ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã§ãããã
ã³ R4ã¯ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã ïŒ C3-6ã·ã¯ãã¢ã«ãã«ã ïŒ ã¢ãªãŒã«âC1-4ã¢ã«ãã«ïŒC1-4ã¢ã«ãã«
éšåã¯çŽéãŸãã¯åæéã§ãããã¢ãªãŒã«
éšåã¯ããšãã«ãŸãã¯ãããã«ã§ãã€ãŠçœ®
æãããªãããŸãã¯C1-3ã¢ã«ãã«ãC1-3ã¢
ã«ã³ãã·ãããããã·ããã³ã¯ããããã«
ãªããŸãã¯ããã¢ã®ãããªããããéžæã
ããïŒãŸãã¯ïŒåã®çœ®æåºã§çœ®æããããïŒ
ã§ãããããæããã æ°èŠãªååç©ã®å¥œé©ãªæ æ§ã¯ R1ãïŒ C1-8ã¢ã«ãã«ç¹ã«ã¡ãã«ãŸãã¯ ïŒ çœ®æãããªããŸãã¯çœ®æãããã¢ãªãŒã«ãç¹
ã«ããšãã«ãŸãã¯ïŒâã¡ããã·ããšãã«ã§
ããã R2ãïŒ C1-8ã¢ã«ãã«ãç¹ã«ã¡ãã«ãŸãã¯ ïŒ ããšãã«ã§ããã R3ãïŒ æ°ŽçŽ ã ïŒ C1-8ã¢ã«ãã«ãç¹ã«ã¡ãã«ãŸãã¯ ïŒ ãããç¹ã«ã¯ããã§ããããã³ R4ãïŒ C1-8ã¢ã«ãã«ãç¹ã«ïŒâãããã«ãŸã
ã¯tertâããã«ã ïŒ ã¢ãªãŒã«âC1-4ã¢ã«ãã«ãç¹ã«C1-4ã¢ã«ãã«
éšåããšãã«ãŸãã¯ïŒâãããã«ã§ããã¢
ãªãŒã«éšåãïŒåã®C1-3ã¢ã«ã³ãã·åºãç¹
ã«ã¡ããã·ã§çœ®æãããããšãã«ã§ãããŸ
ãã¯ ïŒ C3-6ã·ã¯ãã¢ã«ãã«ãç¹ã«ã·ã¯ããããã«ã§
ãã ãšãããã®ã§ããã æ¬çºæã®ååç©ã¯ããããã«åŽéã«äžæççŽ ã
æããããæ (R)âããã³(S)âé¡åç°æ§äœã«å解ã
ãããšãã§ãããæ¬çºæã¯ããããã®å åŠç°æ§äœ
ããã³ã©ã»ãæ··åç©ã®ãããªç°æ§äœã®æ··åç©ãå
å«ããã眮æåºR4ããŸãäžæççŽ ãå å«ããã
ãšãã§ãã第äºã®äžæççŽ ã®å°å ¥ã«ãã€ãŠçãã
ç°æ§äœããã³ãã®æ··åç©ã®ãã¹ãŠã¯æ¬çºæã®ç¯å²
å ãšã¿ãªãããã æ¬çºæã®ååç©ã¯ãŸãç¡æ¯æ§ã®å»è¬çã«äœ¿çšã
åŸãé žä»å å¡©ããã³ç¬¬åã¢ã³ã¢ããŠã å¡©ãå å«ã
ããé žä»å å¡©ã¯ãååç©ãé©åœãªææ©ãŸãã¯ç¡æ©
å¡©ã®é©åœéãšåŠçããããšã«ãã€ãŠè£œé ãããã
æçšãªææ©é žã®å ·äœäŸã¯ããã¬ã€ã³é žãé ç³é žã
é ¢é žããã¢é žãã·ãŠãŠé žãããããªã³é žããµãªã
ã«é žãã³ãã¯é žãã¯ãšã³é žããã¬ã€ã³é žãã€ã»ã
ãªã³é žãªã©ã®ãããªã«ã«ãã³é žã§ãããæçšãªç¡
æ©é žã¯ãå¡©é žãèåæ°ŽçŽ é žãç¡«é žããªã³é žãªã©ã®
ãããªãããããé žã§ããã 第åçŽå¡©ã¯ãäŸãã°ç¬¬äžçŽã¢ãã³åºâNHR1ã
æããæ¬çºæã®ããããååç©ããšãŠåãšãã«ãŸ
ãã¯ãšãŠåã¡ãã«ã®ãããªããã²ã³åã¢ã«ãã«å¥œ
ãŸããã¯ãšãŠåç©ãšã¡ã¿ããŒã«ãŸãã¯ãžã¡ãã«ã
ã«ã ã¢ããïŒDMFïŒã®ãããªé©åœãªæº¶åªäžã§å
å¿ãããããããé©åœãªæ¹æ³ã«ãã€ãŠè£œé ãã
ããåå¿ã¯äžè¬ã«å®€æž©ã§è¡ãããã第åçŽã¢ã³ã¢
ããŠã å¡©ã¯çŽæ¥ã«æº¶å€ãé€å»ããããšã«ãã€ãŠåŸ
ãããã æ¬çºæã®æ°èŠãªæ¹æ³ã¯æ¬¡ã®éãæãããšãã§ã
ãã R5ã¯ããšãã«ã眮æããšãã«ããããã¢ã«ã
ãããªã©ã®ãããªã¢ãªãŒã«ãŸãã¯C1-3ã¢ã«ãã«ã§
ããã ïŒâããããã·ããªããžã³äžéäœïŒã¯ãåœè©²æ
è¡ã«ç¥ãããããããæ¹æ³ãç¹ã«ãšã«ããŒããšã«
㺠ããããµã€ã¯ãªããã³ã³ããŠã³ãºç¬¬ïŒå·»ã«èš
èŒãããæ¹æ³ã«ãã€ãŠè£œé ããããšãã§ããã奜
é©ãªæ¹æ³ã¯ãåå¿æ©æ§ã«ç€ºãããéããã¿ã€ãïŒ
ã®çœ®æβâã±ããšã¹ãã«ãšã¢ããžã³ïŒãšã®åå¿ã
çµãã æ¹æ³ïŒ¡ïŒïŒâããããã·ããªããžã³ãïŒããªã
ãµãŸãªãžã³ãã·ã¬ãŒããïŒãšåå¿ãããããã·ã¬
ãŒãåºã¯ã¡ã·ã¬ãŒããããªãã¬ãŒããŸãã¯ãšãŒã
ã€ãã®ãããªããããä»ã®é©åœãªæ®åºã«ãã€ãŠçœ®
æããããšãã§ãããåå¿ã¯ãNaHãNaOCH3ã
NaOHãã«ãªãŠã tertâãããã·ãªã©ã®ãããªå¡©
åºã奜é©ã«ã¯NaHã®ååšäžãDMSOãDMFãã
ã«ãšã³ãã¡ã¿ããŒã«ãæ°Žãªã©ã®ãããªé©åœãªæº¶
åªãç¹ã«DMFäžçŽïŒâãã溶åªã®éæµæž©åºŠãŸã§
枩床ã§çŽïŒã48æéã«ããã€ãŠã奜é©ã«ã¯çŽ110
âã§18æéè¡ãªãããªããµãŸãªãžã³äžéäœãåŸ
ãã次ã«ãªããµãŸãªãžã³äžéäœãHCl氎溶液ã
H2SO4ãCH3COOHãªã©ã®ãããªé žãçšããŠã
çŽïŒâãã溶åªã®éæµæž©åºŠãŸã§ã®æž©åºŠã§çŽ15åã
ã15æéã奜é©ã«ã¯1N HCläž15åé100âã§é ž
å æ°Žå解ã«å§ããŠïŒâããªããžã³ãïŒãåŸãã æ¹æ³ïŒ¢ïŒæ¹æ³ïŒ¢ã§ã¯ãïŒâããããã·ããªããž
ã³ãïŒãéå°ã®è©Šè¬ããã³ãŒã³ããã«ãšã³ã
THFãªã©ã®ãããªæº¶åªäžPOCl3ãPCl5ãSOCl2
ãªã©ãçšããçŽïŒâãã溶åªã®éæµæž©åºŠãŸã§ã®æž©
床ã§ïŒã12æéã奜é©ã«ã¯ãPOCl3ã§éæµäžïŒæ
éãïŒâã¯ããããªããžã³ã«è»¢åããŠïŒâã¯ãã
ããªããžã³ãïŒãåŸãã NaHãNaOCH3ãã«ãªãŠã tertâãããã·ã
ãªã©ã®ãããªé©åœãªå¡©åºã奜é©ã«ã¯NaHã®ååš
äžãDMSOãDMFããã«ãšã³ãCH3OHãªã©ã®
ãããªé©åœãªæº¶åªã奜é©ã«ã¯DMFäžãçŽïŒâã
ã溶åªã®éæµæž©åºŠãŸã§ã®æž©åºŠã§ãçŽïŒã48æéã«
ããã€ãŠã奜é©ã«ã¯110âã§18æéïŒããªããµãŸ
ãªãžã³ïŒãšåå¿ãããŠããªããµãŸãªãžã³äžéäœã
çæããã æ¹æ³ïŒ£ã§ã¯ãïŒâããããã·ããªããžã³ãïŒã
ãŸãå¡©åºããã³ãã·ã¬ãŒããããªãã¬ãŒããŸãã¯
ãšãŒãã€ããšããŠã«ããç¹èš±ç¬¬965787å·ã«èšèŒã
ããæ¹æ³ã«åŸã€ãŠèª¿è£œãããªããµãŸãªãžãã³ã¡ã·
ã¬ãŒããïŒã奜é©ã«ã¯å¡©åºãšããŠNaHã溶åªãš
ããŠDMSOãçšã60âã§ïŒæéåå¿ããã次ã«
NaOHãKOHãªã©ã®ãããªæ°Žæ§å¡©åºã§ã¡ã¿ããŒ
ã«ããšã¿ããŒã«ãã¢ã»ãã³ãTHFãªã©ã®ãããª
é©åœãªæº¶åªäžïŒã40ïŒ ïŒ·ïŒïŒ¶åŒ·åºŠã§ïŒå¥œé©ã«ã¯10
ïŒ NaOHâC2H5OHïŒïŒïŒïŒïŒã溶åªã®éæµäžçŽ
15åãã24æéã«ããã€ãŠã奜é©ã«ã¯ã100âã§
ïŒæéåŠçããŠãïŒâããªããžã³ãïŒãçæã
ãã æ¬çºæã®æ°èŠãªååç©ã¯ãå¿èéžæβâã¢ãã¬
ããªã³å容äœé®æå€ãšããŠæŽ»æ§ã§ãããåŸã€ãŠæ
é«è¡å§å€ãå¿èä¿è·å€ãæäžæŽèå€ããã³æã¢ã³
ã®ãå€ãšããŠæçšã§ããã æé«è¡å§å€ããã³ïŒãŸãã¯Î²âã¢ãã¬ããªã³é®
æå€ãšããŠã®çšéã«ãæ¬çºæã®ååç©ã¯ãçµç®ç
ã«ãçµç®çã«ãŸãã¯éçµå£çã«ãå³ã¡éèå ã«ã
è ¹èéãªã©ã«ããã³ããããé©åœãªçšé圢æ ã§æ
äžããããšãã§ãããååç©ã¯ãçµå£æäžãšããŠ
圢æ (a)ãäŸãã°ã¿ã«ã¯ãæ€ç©æ²¹ãããªãªãŒã«ãã
ã³ãžã«ã¢ã«ã³ãŒã«ããŽã ããŒã©ãã³ãã¹ã¿ãŒãã
ãã³ä»ã®æ äœã®ãããªæ £ç¿äžäœ¿çšãããä»ã®é å
æåãšäœµçšããé å€ãšããŠãé©åœãªæ¶²äœæ äœã«å
æ£ãŸãã¯ä¹³åããŠãã«ãã»ã«å€ãŸãã¯é©åœãªã«ã
ã»ã«åææã§ã«ãã»ã«åããŠãŸãã¯éçµå£æäžãš
ããŠ(b)ãäŸãã°é©åœãªæ¶²äœæ äœãŸãã¯ä¹³åå€ã«æº¶
解ãŸãã¯åæ£ããŠãŸãã¯çµç®æäžã«å¯ŸããŠãšã¢ã
ãŸã«ãŸãã¯è¬å€æµžé貌å€ãšããŠ(c)æäŸããããšã
ã§ãããäžè¬ã«ïŒæ¥åœãäœéïŒKgã«ã€ãçŽ0.01ã
50mgã奜é©ã«ã¯çŽ0.1ã20mgïŒKgïŒæ¥ã®æ°èŠãªå
åç©ã®æçšéã䜿çšãããçšéã¯å¿ èŠãšããæ¥çš
éããã³åäœçšéã«äŸåããŠäžåãŸãã¯è€æ°åã§
ããããšãã§ããã å®æœäŸ ïŒ (S)âïŒâã¯ããâNâ²âãïŒâïŒïŒïŒïŒâãžã¡ã
ãã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·
ãããã«ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âã¡ãã«âïŒâããªããã³ãããã¯ããªã 段éïŒïŒâã¯ããâïŒâããããã·âïŒâã¡ã
ã«ããªããžã³ã®è£œé N2äžCHCl3ïŒ50mlïŒäžã®ãšãã«ïŒâã¯ããã¢ã»
ãã¢ã»ããŒãïŒ1.8mlãïœïŒ1.15ã0.013ã¢ã«ïŒã®
溶液ãCHCl3ïŒ100mlïŒäžïŒâã¡ããã·ãã³ã¶ããž
ã³ïŒ3.9ïœã0.026ã¢ã«ïŒã®æº¶æ¶²ã«æ»Žå ãããäžæ©
æ¹æããåŸãåå¿æ··å液ãéãã液ãåž
NaOH溶液ã§æŽæµãããæ°Žå±€ãCH2Cl2ïŒ3XïŒã§
æœåºããææ©å±€ã也ç¥ãéããã³æ¿çž®ä¹Ÿåºã
ããæ®æž£ãã·ãªã«ã²ã«äžã§ã¯ãããã°ã©ãã€åŠç
ããçæç©ãïŒïŒ CH3OHâCHCl3ïŒïŒ¶ïŒïŒ¶ïŒã§
溶é¢ããŠçæç©m.p.250ã251âã0.7ïœïŒ22ïŒ ïŒ
åŸãã 段éïŒ(S)âïŒâã¯ããâNâ²âãïŒâïŒïŒïŒïŒâ
ãžã¡ããã·ããšãã«ãšãã«ã¢ããïŒâïŒ
âããããã·ãããã«ãâïŒâïŒïŒâã¡ã
ãã·ããšãã«ïŒâïŒâã¡ãã«âïŒâããª
ããã³ãããã¯ããªãã®è£œé 以äžDMSOïŒ20mlïŒäžã®æ®µéïŒ0.5ïœãïŒããª
ã¢ã«ïŒããã®çæç©ãNaHïŒ60ïŒ æ²¹åæ£æ¶²ã0.09
ïœã2.25ããªã¢ã«ïŒã®æ··å液ã60âã§0.5æéå
ç±ãããDMSOïŒ20mlïŒäž(S)âïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ïŒâïŒâïŒããããã·ã¡ã
ã«ïŒãªããµãŸãªãâïŒâãªã³ã¡ã·ã¬ãŒãïŒ0.72
ïœãïŒããªã¢ã«ïŒã®æº¶æ¶²ã滎å ããã60âã§15æ
éåŸãæ··å液ãæ°Žã«æ³šå ¥ããæ°ŽçžãCH2Cl2ïŒ3XïŒ
ã§æœåºãããææ©å±€ãH2Oã飜åNaClã§éæŽæµ
ãã也ç¥ãéããã³æ¿çž®ä¹Ÿåºãããæ®æž£ããšã¿
ããŒã«ïŒ25mlïŒããã³10ïŒ NaOHïŒ25mlïŒã§åŠç
ããéæµäžã§å ç±ãããïŒæéåŸåå¿æ¶²ãå·åŽ
ããæ°Žã«æ³šå ¥ããæ°ŽçžãCHCl3ïŒ3XïŒã§æœåºã
ããææ©æœåºæ¶²ã也ç¥ãéãæ¿çž®ä¹Ÿåºãããæ®
枣ãã·ãªã«äžã¯ãããã°ã©ãåŠçããŠãçæç©ã
NH3ã§é£œåããïŒïŒ CH3OHâCHCl3ã§æº¶é¢ã
ããç²çæç©ãHClå¡©ã«è»¢åããïŒâãããããŒ
ã«ã§çµæ¶åããŠæçµçæç©155mgïŒ16ïŒ ïŒãm.
p.126ã130âãçæããã å®æœäŸïŒã«èšèŒãããéãïŒâã¯ããâïŒâã¡
ãã«ïŒâïŒïœâã¡ããã·ããšãã«ïŒâããªããžã³â
ïŒâãªã³ã®ä»£ããã«ïŒïŒïŒïŒïŒâããªã¡ãã«ããª
ããžã³âïŒâãªã³ãçšããŠã(S)âNâ²âãïŒâïŒïŒïŒ
ïŒâãžã¡ããã·ããšãã«ãšãã«ïŒã¢ããâïŒâã
ãããã·ãããã«ãâïŒïŒïŒïŒïŒâããªã¡ãã«ã
ãªããžã³âïŒâãªã³ãçæããã å®æœäŸ ïŒ (S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«
ãšãã«ã¢ããïŒâïŒâããããã·ãããã«ãâïŒ
âïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«âïŒâ
ããªããã³ãããã¯ããªãã»ã¹ãæ°Žåç© æ®µéïŒïŒâããããã·âïŒâã¡ãã«âïŒâïœâ
ã¡ããã·ããšãã«ããªãžã³ N2äžãCHCl3ïŒ200mlïŒäžã®ãšãã«ã¢ã»ãã¢ã»
ããŒãïŒ7.15ïœã0.053ã¢ã«ïŒã®æº¶æ¶²ãCHCl3ïŒ200
mlïŒäžã®ïŒâã¡ããã·ãã³ã¶ããžã³ã®æžæ¿æ¶²ã«æ»Ž
å ãããäžæ©å®€æž©ã§æ¹æããåŸããã®æº¶æ¶²ã«æ°Žã
æ·»å ãããæ°Žå±€ãåé¢ããCHCl3ã§æœåºããææ©
å±€ãåããã也ç¥ïŒNa2SO4ïŒãéããã³æ¿çž®
也åºãããæ®æž£ãã·ãªã«ã²äžã§ã¯ããã°ã©ãã€åŠ
çããçæç©ãïŒïŒ CH3OHâCHCl3ã§æº¶é¢ããŠ
çæç©ãm.p.198ã199âã8.58ïœïŒ75ïŒ ïŒãåŸ
ãã 段éïŒ(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ããã·ã
ãšãã«ãšãã«ã¢ããïŒâïŒâããããã·
ãããã«ãâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âïŒâããªããã³ãã
ãã¯ããªããã»ã¹ãæ°Žåç© N2äžãNaHïŒ722mgã0.018ã¢ã«ïŒãDMSOïŒ150
mlïŒäžã®æ®µéããã®çæç©ïŒ3.5ïœã0.016ã¢
ã«ïŒã®æº¶æ¶²ã«æ·»å ããæ··å液ã60âã§0.5æéæ¹
æãããDMSOïŒ150mlïŒäž(S)âïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ïŒâïŒâïŒããããã·ã¡ã
ã«ïŒãªããµãŸãªãâïŒâãªã³ã¡ã·ã¬ãŒãïŒ5.8ïœã
0.016ã¢ã«ïŒã®æº¶æ¶²ã滎å ãããæ·»å ããåŸã溶
液ã60âã§äžæ©æ¹æããã次ã«åå¿æ··å液ã氷济
ã§å·åŽããæ°Žã«æ³šå ¥ããCH2Cl2ã§æœåºãããå
ãããææ©å±€ãæ°Žã§æŽæµãã也ç¥ïŒNa2SO4ïŒ
éããã³èžçºä¹Ÿåºãããæ®æž£ãç¡æ°Žãšã¿ããŒã«
ïŒ180mlïŒããã³10ïŒ NaOHïŒ180mlïŒã§ïŒæéé
æµãã宀枩ã«å·åŽãH2Oã«æ³šå ¥ããã³CHCl3ã§æœ
åºãããåãããææ©å±€ãæ°Žããã³NaCl飜å溶
液ã§æŽæµã也ç¥ïŒNa2SO4ïŒãéããã³èžçºä¹Ÿ
åºãããæ®æž£ã6Nãšã¿ããŒã«æ§HCl溶液ïŒ12mlïŒ
ãšæ¹æããŠå¡©é žå¡©ãçæããïŒâãããããŒã«ã§
åçµæ¶ããŠçæç©3.70ïœïŒ45ïŒ ïŒãåŸã
C25H31N3O5ã»HCl1 1/2H2OãšããŠè£æ£ããŠåæ
ãããæ§é ã¯360MHz 1HNMRããã³ 13Cåå å
æã«ãã€ãŠç¢ºèªããã å®æœäŸïŒã«èšèŒãããéãïŒâã¡ãã«âïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒããªããžã³âïŒâãªã³
ã®ä»£ããã«ïŒïŒïŒïŒïŒâããªã¡ãã«ããªããžã³â
ïŒâãªã³ãïŒâã¡ãã«âïŒâããšãã«ããªããžã³
âïŒâãªã³ãïŒâã¡ãã«âïŒâããšãã«ããªããž
ã³âïŒâãªã³ããã³ïŒïŒïŒâãžããšãã«ããªããž
ã³âïŒâãªã³ãçšããŠ(S)âNâ²ãïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ïŒã¢ããâïŒâãããã
ã·ãããã«ãâïŒïŒïŒïŒïŒâããªã¡ãã«ããªããž
ã³âïŒâãªã³ã(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ã
ãã·ããšãã«ãšãã«ïŒã¢ããâïŒâããããã·ã
ããã«ãâïŒâã¡ãã«âïŒâããšãã«ããªããžã³
âïŒâãªã³ã(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ãã
ã·ããšãã«ãšãã«ïŒâã¢ããâïŒâããããã·ã
ããã«ãâïŒâã¡ãã«âïŒâããšãã«ããªããžã³
âïŒâãªã³ããã³(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡
ããã·ããšãã«ãšãã«ïŒã¢ããâïŒâããããã·
ãããã«ãâïŒïŒïŒâãžããšãã«ããªããžã³âïŒ
âãªã³ãåã çæããã å®æœäŸ ïŒ (S)âNâ²âïŒïŒâã€ãœãããã«ã¢ããâïŒâãã
ããã·ãããã«ïŒâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âïŒâããªããã³ãããã¯ã
ãªãåæ°Žåç© N2äžãNaHïŒ722mgã0.018ã¢ã«ïŒãDMSOïŒ150
mlïŒäžã®ïŒâããããã·âïŒâã¡ãã«âïŒâïŒïœ
âã¡ããã·ããšãã«ïŒããªããžã³ïŒ3.5ïœã0.016
ã¢ã«ïŒã®æº¶æ¶²ã«æ·»å ããæ··å液ã60âã§0.5æé
æ¹æãããDMSOïŒ150mlïŒäž(S)âïŒâïŒïŒâãã
ãã«ïŒâïŒâããããã·ã¡ãã«ãªããµãŸãªãâïŒ
âãªã³ã¡ã·ã¬ãŒãïŒ3.95ïœã0.016ã¢ã«ïŒã®æº¶æ¶²
ã滎å ããæ··å液ã60âã§äžæ©æ¹æããã次ã«å
å¿æ··å液ã宀枩ã«å·åŽããæ°Žã«æ³šå ¥ããCHCl3ã§
æœåºãããåãããææ©å±€ãæ°Žããã³NaCl飜å
溶液ã§æŽæµãã也ç¥ïŒNa2SO4ïŒãéããã³èž
çºä¹Ÿåºãããæ®æž£ãéæµäžç¡æ°Žãšã¿ããŒã«ïŒ180
mlïŒããã³10ïŒ NaOHïŒ180mlïŒãšïŒæéå ç±ãã
宀枩ã«å·åŽããH2Oã«æ³šå ¥ããŠCHCl3ã§æœåºã
ããåãããææ©å±€ãH2Oããã³NaCl飜å溶液
ã§æŽæµãã也ç¥ïŒNa2SO4ïŒããŠèžçºä¹Ÿåºããã
æ®æž£ã溶é¢æ¶²ãšããŠïŒïŒ CH3OHâCHCl3ã§ã·ãª
ã«ã²ã«äžã¯ãããã°ã©ãã€åŠçãããåŸãããé
é¢å¡©åºã6Nã»HClâãšã¿ããŒã«æº¶æ¶²ïŒ2.1mlïŒã§
åŠçããŠå¡©é žå¡©ã«è»¢åãããå¡©ãïŒâãããããŒ
ã«ã§åçµæ¶ããŠãçæç©780mgïŒ13ïŒ ïŒãçæãã
C18H25N3O3HClã»1/2H2OãšããŠè£æ£ããŠåæã
ããæ§é ã¯360MHzHNMRããã³ 13Cåå åæã«
ãã€ãŠç¢ºèªããã å®æœäŸïŒã«èšèŒãããéãïŒâã¡ãã«âïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒããªããžã³âïŒâãªã³
ã®ä»£ãã«ïŒâã¡ãã«âïŒâããšãã«ããªããžã³â
ïŒâãªã³ãçšããŠ(S)âNâ²âïŒïŒâã€ãœãããã«ã¢
ããâïŒâããããã·ãããã«ïŒâïŒâã¡ãã«â
ïŒâããšãã«ããªããžã³âïŒâãªã³ãçæããã å®æœäŸ ïŒ (S)âïŒâã¯ããâïŒâãïŒâïŒïŒïŒïŒâãžã¡ãã
ã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·ã
ãããã·ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âã¡ãã«ããªããžã³ 段éïŒïŒïŒïŒâãžã¯ããâïŒâã¡ãã«âïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒããªããžã³ã®
補é ïŒâã¯ããâïŒâããããã·âïŒâïŒïŒâã¡ã
ãã·ããšãã«ïŒâïŒâã¡ãã«ããªããžã³ïŒ1.0ïœã
0.004ã¢ã«ïŒããã³POCl3ïŒïŒmlïŒã®æ··å液ãN2äž
éæµäžã§ïŒæéå ç±ãã次ã«ïŒâã§16æéæŸçœ®ã
ããæ°·ãæ·»å ããPHã10ïŒ NaOHã§å¡©åºæ§ã«ã
ãã溶液ãCH2Cl2ã§æœåºãããåãããææ©å±€
ãæ°Žã§æŽæµãã也ç¥ïŒNa2SO4ïŒãéããã³èž
çºä¹Ÿåºãããæ®æž£ããšãã«ã¢ã»ããŒãâãããµã³
ã§åçµæ¶ããŠçæç©710mgïŒ66ïŒ ïŒãåŸããæ§é
ãMSããã³90MHz 1HNMRã«ãã€ãŠç¢ºèªããã 段éïŒ(S)âïŒâã¯ããâïŒâãïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ã¢ããïŒâïŒâ
ããããã·ããããã·ãâïŒâïŒïŒâã¡ã
ãã·ããšãã«ïŒâïŒâã¡ãã«ããªããžã³
ã®è£œé N2äžãNaHïŒ120mgã0.003ã¢ã«ïŒãDMFïŒ15
mlïŒäžã®ïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«ãšã
ã«ïŒâïŒâããããã·ã¡ãã«âïŒâããšãã«ãªã
ãµãŸãªãžã³ïŒ1.03ïœã0.003ã¢ã«ïŒã®æº¶æ¶²ã«æ·»å
ããæ··å液ã60âã§0.5æéæ¹æããã枩床ã25
âã«äœäžãããDMFïŒ15mlïŒäžæ®µéããã®çæ
ç©ïŒ690mgã0.003ã¢ã«ïŒã®æº¶æ¶²ãæ·»å ããã溶液
ã60âã§äžæ©æ¹æãããåå¿æ··å液ã宀枩ã«å·åŽ
ããDMFãæžå§äžã§é€å»ãããæ®æž£ãæ°Žããã³
CH2Cl2ã«åé ãããå¡©åºæ§æ°Žå±€ãCH2Cl2ã§æœåº
ãããåãããææ©å±€ãæ°Žã§æŽæµãã也ç¥
ïŒNa2SO2ïŒãéããã³èžçºä¹Ÿåºããã æ®æž£ã溶é¢æ¶²ãšããŠïŒïŒ ïŒâãããããŒã«â
CH2Cl2ãçšããŠã·ãªã«ã²ã«äžã¯ããã°ã©ãã€åŠ
çããCH3CNã§ïŒååçµæ¶ããŠçæç©ãm.p.94
ã95âã50mgïŒïŒïŒ ïŒãåŸãC25H30N3O5Clãšã
ãŠè£æ£ããŠåæãããæ§é ã360MHzã®HNMR
ã«ãã€ãŠç¢ºèªããã å®æœäŸïŒã«èšèŒãããéããïŒâã¯ããâïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«ããªããžã³
âïŒâãªã³ã®ä»£ããã«ïŒâã¡ãã«âïŒâããšãã«
ããªããžã³âïŒâãªã³ããã³ïŒïŒïŒâãžããšãã«
ããªããžã³âïŒâãªã³ãçšããŠåã ïŒâã¯ããâ
ïŒâã¡ãã«âïŒâããšãã«ããªããžã³ããã³ïŒâ
ã¯ããâïŒïŒïŒâãžããšãã«ããªããžã³ãåŸãã å®æœäŸïŒã«èšèŒãããéããïŒïŒïŒâãžã¯ãã
âïŒâã¡ãã«âïŒâïŒïœâã¡ããã·ããšãã«ïŒã
ãªããžã³ã®ä»£ããã«ïŒâã¯ããâïŒâã¡ãã«âïŒ
âããšãã«ããªããžã³ããã³ïŒâã¯ããâïŒïŒïŒ
âãžããšãã«ããªããžã³ãçšããŠã(S)âïŒâã¯ã
ãâïŒâãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«ãšã
ã«ïŒã¢ããâïŒâããããã·ããããã·ãïŒâã¡
ãã«âïŒâããšãã«ããªããžã³ããã³(S)âïŒâã¯
ããâïŒâãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«ãš
ãã«ïŒã¢ããâïŒâããããã·ããããã·ãâïŒïŒ
ïŒâãžããšãã«ããªããžã³ãçæããã é©åœãªåºçºç©è³ªãçšããå®è³ªçã«å®æœäŸïŒïŒïŒ
ãŸãã¯ïŒã«èšèŒãããæäœã䜿çšããŠã次ã®åå
ç©ãçæããã
ãã ïœ C1-3ã¢ã«ã³ãã·ãŸãã¯ ïœ C1-3ã¢ã«ãã« ããéžæãããïŒãïŒåã®çœ®æåºã§çœ®æãã
ãããšãã«ãŸãã¯ãããã«ã®ãããªççŽ ç°ã¢ãª
ãŒã«ã ïŒ ããªãžãã«ããã©ãžãã«ãããªããžãã«ãã
ãšãã«ãããªã«ãâã¡ãã«ããªã«ãªã©ã®ãã
ãªïŒãŸãã¯ïŒå¡ã®è€çŽ ç°ã¢ãªãŒã«ïŒå°ãªããšã
ïŒå¡ãççŽ ã§ããããããååã¯ïŒ¯ïŒïŒ®ãŸãã¯
ã§ããïŒã§ããã R3ã¯ïŒ æ°ŽçŽ ã ïŒ ãã«ãªããã¯ãããŸãã¯ããã¢ã奜ãŸããã¯
ãã«ãªããŸãã¯ã¯ããã®ãããªããã ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã§ãããã
ã³ R4ã¯ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã ïŒ C3-6ã·ã¯ãã¢ã«ãã«ã ïŒ ã¢ãªãŒã«âC1-4ã¢ã«ãã«ïŒC1-4ã¢ã«ãã«
éšåã¯çŽéãŸãã¯åæéã§ãããã¢ãªãŒã«
éšåã¯ããšãã«ãŸãã¯ãããã«ã§ãã€ãŠçœ®
æãããªãããŸãã¯C1-3ã¢ã«ãã«ãC1-3ã¢
ã«ã³ãã·ãããããã·ããã³ã¯ããããã«
ãªããŸãã¯ããã¢ã®ãããªããããéžæã
ããïŒãŸãã¯ïŒåã®çœ®æåºã§çœ®æããããïŒ
ã§ãããããæããã æ°èŠãªååç©ã®å¥œé©ãªæ æ§ã¯ R1ãïŒ C1-8ã¢ã«ãã«ç¹ã«ã¡ãã«ãŸãã¯ ïŒ çœ®æãããªããŸãã¯çœ®æãããã¢ãªãŒã«ãç¹
ã«ããšãã«ãŸãã¯ïŒâã¡ããã·ããšãã«ã§
ããã R2ãïŒ C1-8ã¢ã«ãã«ãç¹ã«ã¡ãã«ãŸãã¯ ïŒ ããšãã«ã§ããã R3ãïŒ æ°ŽçŽ ã ïŒ C1-8ã¢ã«ãã«ãç¹ã«ã¡ãã«ãŸãã¯ ïŒ ãããç¹ã«ã¯ããã§ããããã³ R4ãïŒ C1-8ã¢ã«ãã«ãç¹ã«ïŒâãããã«ãŸã
ã¯tertâããã«ã ïŒ ã¢ãªãŒã«âC1-4ã¢ã«ãã«ãç¹ã«C1-4ã¢ã«ãã«
éšåããšãã«ãŸãã¯ïŒâãããã«ã§ããã¢
ãªãŒã«éšåãïŒåã®C1-3ã¢ã«ã³ãã·åºãç¹
ã«ã¡ããã·ã§çœ®æãããããšãã«ã§ãããŸ
ãã¯ ïŒ C3-6ã·ã¯ãã¢ã«ãã«ãç¹ã«ã·ã¯ããããã«ã§
ãã ãšãããã®ã§ããã æ¬çºæã®ååç©ã¯ããããã«åŽéã«äžæççŽ ã
æããããæ (R)âããã³(S)âé¡åç°æ§äœã«å解ã
ãããšãã§ãããæ¬çºæã¯ããããã®å åŠç°æ§äœ
ããã³ã©ã»ãæ··åç©ã®ãããªç°æ§äœã®æ··åç©ãå
å«ããã眮æåºR4ããŸãäžæççŽ ãå å«ããã
ãšãã§ãã第äºã®äžæççŽ ã®å°å ¥ã«ãã€ãŠçãã
ç°æ§äœããã³ãã®æ··åç©ã®ãã¹ãŠã¯æ¬çºæã®ç¯å²
å ãšã¿ãªãããã æ¬çºæã®ååç©ã¯ãŸãç¡æ¯æ§ã®å»è¬çã«äœ¿çšã
åŸãé žä»å å¡©ããã³ç¬¬åã¢ã³ã¢ããŠã å¡©ãå å«ã
ããé žä»å å¡©ã¯ãååç©ãé©åœãªææ©ãŸãã¯ç¡æ©
å¡©ã®é©åœéãšåŠçããããšã«ãã€ãŠè£œé ãããã
æçšãªææ©é žã®å ·äœäŸã¯ããã¬ã€ã³é žãé ç³é žã
é ¢é žããã¢é žãã·ãŠãŠé žãããããªã³é žããµãªã
ã«é žãã³ãã¯é žãã¯ãšã³é žããã¬ã€ã³é žãã€ã»ã
ãªã³é žãªã©ã®ãããªã«ã«ãã³é žã§ãããæçšãªç¡
æ©é žã¯ãå¡©é žãèåæ°ŽçŽ é žãç¡«é žããªã³é žãªã©ã®
ãããªãããããé žã§ããã 第åçŽå¡©ã¯ãäŸãã°ç¬¬äžçŽã¢ãã³åºâNHR1ã
æããæ¬çºæã®ããããååç©ããšãŠåãšãã«ãŸ
ãã¯ãšãŠåã¡ãã«ã®ãããªããã²ã³åã¢ã«ãã«å¥œ
ãŸããã¯ãšãŠåç©ãšã¡ã¿ããŒã«ãŸãã¯ãžã¡ãã«ã
ã«ã ã¢ããïŒDMFïŒã®ãããªé©åœãªæº¶åªäžã§å
å¿ãããããããé©åœãªæ¹æ³ã«ãã€ãŠè£œé ãã
ããåå¿ã¯äžè¬ã«å®€æž©ã§è¡ãããã第åçŽã¢ã³ã¢
ããŠã å¡©ã¯çŽæ¥ã«æº¶å€ãé€å»ããããšã«ãã€ãŠåŸ
ãããã æ¬çºæã®æ°èŠãªæ¹æ³ã¯æ¬¡ã®éãæãããšãã§ã
ãã R5ã¯ããšãã«ã眮æããšãã«ããããã¢ã«ã
ãããªã©ã®ãããªã¢ãªãŒã«ãŸãã¯C1-3ã¢ã«ãã«ã§
ããã ïŒâããããã·ããªããžã³äžéäœïŒã¯ãåœè©²æ
è¡ã«ç¥ãããããããæ¹æ³ãç¹ã«ãšã«ããŒããšã«
㺠ããããµã€ã¯ãªããã³ã³ããŠã³ãºç¬¬ïŒå·»ã«èš
èŒãããæ¹æ³ã«ãã€ãŠè£œé ããããšãã§ããã奜
é©ãªæ¹æ³ã¯ãåå¿æ©æ§ã«ç€ºãããéããã¿ã€ãïŒ
ã®çœ®æβâã±ããšã¹ãã«ãšã¢ããžã³ïŒãšã®åå¿ã
çµãã æ¹æ³ïŒ¡ïŒïŒâããããã·ããªããžã³ãïŒããªã
ãµãŸãªãžã³ãã·ã¬ãŒããïŒãšåå¿ãããããã·ã¬
ãŒãåºã¯ã¡ã·ã¬ãŒããããªãã¬ãŒããŸãã¯ãšãŒã
ã€ãã®ãããªããããä»ã®é©åœãªæ®åºã«ãã€ãŠçœ®
æããããšãã§ãããåå¿ã¯ãNaHãNaOCH3ã
NaOHãã«ãªãŠã tertâãããã·ãªã©ã®ãããªå¡©
åºã奜é©ã«ã¯NaHã®ååšäžãDMSOãDMFãã
ã«ãšã³ãã¡ã¿ããŒã«ãæ°Žãªã©ã®ãããªé©åœãªæº¶
åªãç¹ã«DMFäžçŽïŒâãã溶åªã®éæµæž©åºŠãŸã§
枩床ã§çŽïŒã48æéã«ããã€ãŠã奜é©ã«ã¯çŽ110
âã§18æéè¡ãªãããªããµãŸãªãžã³äžéäœãåŸ
ãã次ã«ãªããµãŸãªãžã³äžéäœãHCl氎溶液ã
H2SO4ãCH3COOHãªã©ã®ãããªé žãçšããŠã
çŽïŒâãã溶åªã®éæµæž©åºŠãŸã§ã®æž©åºŠã§çŽ15åã
ã15æéã奜é©ã«ã¯1N HCläž15åé100âã§é ž
å æ°Žå解ã«å§ããŠïŒâããªããžã³ãïŒãåŸãã æ¹æ³ïŒ¢ïŒæ¹æ³ïŒ¢ã§ã¯ãïŒâããããã·ããªããž
ã³ãïŒãéå°ã®è©Šè¬ããã³ãŒã³ããã«ãšã³ã
THFãªã©ã®ãããªæº¶åªäžPOCl3ãPCl5ãSOCl2
ãªã©ãçšããçŽïŒâãã溶åªã®éæµæž©åºŠãŸã§ã®æž©
床ã§ïŒã12æéã奜é©ã«ã¯ãPOCl3ã§éæµäžïŒæ
éãïŒâã¯ããããªããžã³ã«è»¢åããŠïŒâã¯ãã
ããªããžã³ãïŒãåŸãã NaHãNaOCH3ãã«ãªãŠã tertâãããã·ã
ãªã©ã®ãããªé©åœãªå¡©åºã奜é©ã«ã¯NaHã®ååš
äžãDMSOãDMFããã«ãšã³ãCH3OHãªã©ã®
ãããªé©åœãªæº¶åªã奜é©ã«ã¯DMFäžãçŽïŒâã
ã溶åªã®éæµæž©åºŠãŸã§ã®æž©åºŠã§ãçŽïŒã48æéã«
ããã€ãŠã奜é©ã«ã¯110âã§18æéïŒããªããµãŸ
ãªãžã³ïŒãšåå¿ãããŠããªããµãŸãªãžã³äžéäœã
çæããã æ¹æ³ïŒ£ã§ã¯ãïŒâããããã·ããªããžã³ãïŒã
ãŸãå¡©åºããã³ãã·ã¬ãŒããããªãã¬ãŒããŸãã¯
ãšãŒãã€ããšããŠã«ããç¹èš±ç¬¬965787å·ã«èšèŒã
ããæ¹æ³ã«åŸã€ãŠèª¿è£œãããªããµãŸãªãžãã³ã¡ã·
ã¬ãŒããïŒã奜é©ã«ã¯å¡©åºãšããŠNaHã溶åªãš
ããŠDMSOãçšã60âã§ïŒæéåå¿ããã次ã«
NaOHãKOHãªã©ã®ãããªæ°Žæ§å¡©åºã§ã¡ã¿ããŒ
ã«ããšã¿ããŒã«ãã¢ã»ãã³ãTHFãªã©ã®ãããª
é©åœãªæº¶åªäžïŒã40ïŒ ïŒ·ïŒïŒ¶åŒ·åºŠã§ïŒå¥œé©ã«ã¯10
ïŒ NaOHâC2H5OHïŒïŒïŒïŒïŒã溶åªã®éæµäžçŽ
15åãã24æéã«ããã€ãŠã奜é©ã«ã¯ã100âã§
ïŒæéåŠçããŠãïŒâããªããžã³ãïŒãçæã
ãã æ¬çºæã®æ°èŠãªååç©ã¯ãå¿èéžæβâã¢ãã¬
ããªã³å容äœé®æå€ãšããŠæŽ»æ§ã§ãããåŸã€ãŠæ
é«è¡å§å€ãå¿èä¿è·å€ãæäžæŽèå€ããã³æã¢ã³
ã®ãå€ãšããŠæçšã§ããã æé«è¡å§å€ããã³ïŒãŸãã¯Î²âã¢ãã¬ããªã³é®
æå€ãšããŠã®çšéã«ãæ¬çºæã®ååç©ã¯ãçµç®ç
ã«ãçµç®çã«ãŸãã¯éçµå£çã«ãå³ã¡éèå ã«ã
è ¹èéãªã©ã«ããã³ããããé©åœãªçšé圢æ ã§æ
äžããããšãã§ãããååç©ã¯ãçµå£æäžãšããŠ
圢æ (a)ãäŸãã°ã¿ã«ã¯ãæ€ç©æ²¹ãããªãªãŒã«ãã
ã³ãžã«ã¢ã«ã³ãŒã«ããŽã ããŒã©ãã³ãã¹ã¿ãŒãã
ãã³ä»ã®æ äœã®ãããªæ £ç¿äžäœ¿çšãããä»ã®é å
æåãšäœµçšããé å€ãšããŠãé©åœãªæ¶²äœæ äœã«å
æ£ãŸãã¯ä¹³åããŠãã«ãã»ã«å€ãŸãã¯é©åœãªã«ã
ã»ã«åææã§ã«ãã»ã«åããŠãŸãã¯éçµå£æäžãš
ããŠ(b)ãäŸãã°é©åœãªæ¶²äœæ äœãŸãã¯ä¹³åå€ã«æº¶
解ãŸãã¯åæ£ããŠãŸãã¯çµç®æäžã«å¯ŸããŠãšã¢ã
ãŸã«ãŸãã¯è¬å€æµžé貌å€ãšããŠ(c)æäŸããããšã
ã§ãããäžè¬ã«ïŒæ¥åœãäœéïŒKgã«ã€ãçŽ0.01ã
50mgã奜é©ã«ã¯çŽ0.1ã20mgïŒKgïŒæ¥ã®æ°èŠãªå
åç©ã®æçšéã䜿çšãããçšéã¯å¿ èŠãšããæ¥çš
éããã³åäœçšéã«äŸåããŠäžåãŸãã¯è€æ°åã§
ããããšãã§ããã å®æœäŸ ïŒ (S)âïŒâã¯ããâNâ²âãïŒâïŒïŒïŒïŒâãžã¡ã
ãã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·
ãããã«ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âã¡ãã«âïŒâããªããã³ãããã¯ããªã 段éïŒïŒâã¯ããâïŒâããããã·âïŒâã¡ã
ã«ããªããžã³ã®è£œé N2äžCHCl3ïŒ50mlïŒäžã®ãšãã«ïŒâã¯ããã¢ã»
ãã¢ã»ããŒãïŒ1.8mlãïœïŒ1.15ã0.013ã¢ã«ïŒã®
溶液ãCHCl3ïŒ100mlïŒäžïŒâã¡ããã·ãã³ã¶ããž
ã³ïŒ3.9ïœã0.026ã¢ã«ïŒã®æº¶æ¶²ã«æ»Žå ãããäžæ©
æ¹æããåŸãåå¿æ··å液ãéãã液ãåž
NaOH溶液ã§æŽæµãããæ°Žå±€ãCH2Cl2ïŒ3XïŒã§
æœåºããææ©å±€ã也ç¥ãéããã³æ¿çž®ä¹Ÿåºã
ããæ®æž£ãã·ãªã«ã²ã«äžã§ã¯ãããã°ã©ãã€åŠç
ããçæç©ãïŒïŒ CH3OHâCHCl3ïŒïŒ¶ïŒïŒ¶ïŒã§
溶é¢ããŠçæç©m.p.250ã251âã0.7ïœïŒ22ïŒ ïŒ
åŸãã 段éïŒ(S)âïŒâã¯ããâNâ²âãïŒâïŒïŒïŒïŒâ
ãžã¡ããã·ããšãã«ãšãã«ã¢ããïŒâïŒ
âããããã·ãããã«ãâïŒâïŒïŒâã¡ã
ãã·ããšãã«ïŒâïŒâã¡ãã«âïŒâããª
ããã³ãããã¯ããªãã®è£œé 以äžDMSOïŒ20mlïŒäžã®æ®µéïŒ0.5ïœãïŒããª
ã¢ã«ïŒããã®çæç©ãNaHïŒ60ïŒ æ²¹åæ£æ¶²ã0.09
ïœã2.25ããªã¢ã«ïŒã®æ··å液ã60âã§0.5æéå
ç±ãããDMSOïŒ20mlïŒäž(S)âïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ïŒâïŒâïŒããããã·ã¡ã
ã«ïŒãªããµãŸãªãâïŒâãªã³ã¡ã·ã¬ãŒãïŒ0.72
ïœãïŒããªã¢ã«ïŒã®æº¶æ¶²ã滎å ããã60âã§15æ
éåŸãæ··å液ãæ°Žã«æ³šå ¥ããæ°ŽçžãCH2Cl2ïŒ3XïŒ
ã§æœåºãããææ©å±€ãH2Oã飜åNaClã§éæŽæµ
ãã也ç¥ãéããã³æ¿çž®ä¹Ÿåºãããæ®æž£ããšã¿
ããŒã«ïŒ25mlïŒããã³10ïŒ NaOHïŒ25mlïŒã§åŠç
ããéæµäžã§å ç±ãããïŒæéåŸåå¿æ¶²ãå·åŽ
ããæ°Žã«æ³šå ¥ããæ°ŽçžãCHCl3ïŒ3XïŒã§æœåºã
ããææ©æœåºæ¶²ã也ç¥ãéãæ¿çž®ä¹Ÿåºãããæ®
枣ãã·ãªã«äžã¯ãããã°ã©ãåŠçããŠãçæç©ã
NH3ã§é£œåããïŒïŒ CH3OHâCHCl3ã§æº¶é¢ã
ããç²çæç©ãHClå¡©ã«è»¢åããïŒâãããããŒ
ã«ã§çµæ¶åããŠæçµçæç©155mgïŒ16ïŒ ïŒãm.
p.126ã130âãçæããã å®æœäŸïŒã«èšèŒãããéãïŒâã¯ããâïŒâã¡
ãã«ïŒâïŒïœâã¡ããã·ããšãã«ïŒâããªããžã³â
ïŒâãªã³ã®ä»£ããã«ïŒïŒïŒïŒïŒâããªã¡ãã«ããª
ããžã³âïŒâãªã³ãçšããŠã(S)âNâ²âãïŒâïŒïŒïŒ
ïŒâãžã¡ããã·ããšãã«ãšãã«ïŒã¢ããâïŒâã
ãããã·ãããã«ãâïŒïŒïŒïŒïŒâããªã¡ãã«ã
ãªããžã³âïŒâãªã³ãçæããã å®æœäŸ ïŒ (S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«
ãšãã«ã¢ããïŒâïŒâããããã·ãããã«ãâïŒ
âïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«âïŒâ
ããªããã³ãããã¯ããªãã»ã¹ãæ°Žåç© æ®µéïŒïŒâããããã·âïŒâã¡ãã«âïŒâïœâ
ã¡ããã·ããšãã«ããªãžã³ N2äžãCHCl3ïŒ200mlïŒäžã®ãšãã«ã¢ã»ãã¢ã»
ããŒãïŒ7.15ïœã0.053ã¢ã«ïŒã®æº¶æ¶²ãCHCl3ïŒ200
mlïŒäžã®ïŒâã¡ããã·ãã³ã¶ããžã³ã®æžæ¿æ¶²ã«æ»Ž
å ãããäžæ©å®€æž©ã§æ¹æããåŸããã®æº¶æ¶²ã«æ°Žã
æ·»å ãããæ°Žå±€ãåé¢ããCHCl3ã§æœåºããææ©
å±€ãåããã也ç¥ïŒNa2SO4ïŒãéããã³æ¿çž®
也åºãããæ®æž£ãã·ãªã«ã²äžã§ã¯ããã°ã©ãã€åŠ
çããçæç©ãïŒïŒ CH3OHâCHCl3ã§æº¶é¢ããŠ
çæç©ãm.p.198ã199âã8.58ïœïŒ75ïŒ ïŒãåŸ
ãã 段éïŒ(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ããã·ã
ãšãã«ãšãã«ã¢ããïŒâïŒâããããã·
ãããã«ãâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âïŒâããªããã³ãã
ãã¯ããªããã»ã¹ãæ°Žåç© N2äžãNaHïŒ722mgã0.018ã¢ã«ïŒãDMSOïŒ150
mlïŒäžã®æ®µéããã®çæç©ïŒ3.5ïœã0.016ã¢
ã«ïŒã®æº¶æ¶²ã«æ·»å ããæ··å液ã60âã§0.5æéæ¹
æãããDMSOïŒ150mlïŒäž(S)âïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ïŒâïŒâïŒããããã·ã¡ã
ã«ïŒãªããµãŸãªãâïŒâãªã³ã¡ã·ã¬ãŒãïŒ5.8ïœã
0.016ã¢ã«ïŒã®æº¶æ¶²ã滎å ãããæ·»å ããåŸã溶
液ã60âã§äžæ©æ¹æããã次ã«åå¿æ··å液ã氷济
ã§å·åŽããæ°Žã«æ³šå ¥ããCH2Cl2ã§æœåºãããå
ãããææ©å±€ãæ°Žã§æŽæµãã也ç¥ïŒNa2SO4ïŒ
éããã³èžçºä¹Ÿåºãããæ®æž£ãç¡æ°Žãšã¿ããŒã«
ïŒ180mlïŒããã³10ïŒ NaOHïŒ180mlïŒã§ïŒæéé
æµãã宀枩ã«å·åŽãH2Oã«æ³šå ¥ããã³CHCl3ã§æœ
åºãããåãããææ©å±€ãæ°Žããã³NaCl飜å溶
液ã§æŽæµã也ç¥ïŒNa2SO4ïŒãéããã³èžçºä¹Ÿ
åºãããæ®æž£ã6Nãšã¿ããŒã«æ§HCl溶液ïŒ12mlïŒ
ãšæ¹æããŠå¡©é žå¡©ãçæããïŒâãããããŒã«ã§
åçµæ¶ããŠçæç©3.70ïœïŒ45ïŒ ïŒãåŸã
C25H31N3O5ã»HCl1 1/2H2OãšããŠè£æ£ããŠåæ
ãããæ§é ã¯360MHz 1HNMRããã³ 13Cåå å
æã«ãã€ãŠç¢ºèªããã å®æœäŸïŒã«èšèŒãããéãïŒâã¡ãã«âïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒããªããžã³âïŒâãªã³
ã®ä»£ããã«ïŒïŒïŒïŒïŒâããªã¡ãã«ããªããžã³â
ïŒâãªã³ãïŒâã¡ãã«âïŒâããšãã«ããªããžã³
âïŒâãªã³ãïŒâã¡ãã«âïŒâããšãã«ããªããž
ã³âïŒâãªã³ããã³ïŒïŒïŒâãžããšãã«ããªããž
ã³âïŒâãªã³ãçšããŠ(S)âNâ²ãïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ïŒã¢ããâïŒâãããã
ã·ãããã«ãâïŒïŒïŒïŒïŒâããªã¡ãã«ããªããž
ã³âïŒâãªã³ã(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ã
ãã·ããšãã«ãšãã«ïŒã¢ããâïŒâããããã·ã
ããã«ãâïŒâã¡ãã«âïŒâããšãã«ããªããžã³
âïŒâãªã³ã(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ãã
ã·ããšãã«ãšãã«ïŒâã¢ããâïŒâããããã·ã
ããã«ãâïŒâã¡ãã«âïŒâããšãã«ããªããžã³
âïŒâãªã³ããã³(S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡
ããã·ããšãã«ãšãã«ïŒã¢ããâïŒâããããã·
ãããã«ãâïŒïŒïŒâãžããšãã«ããªããžã³âïŒ
âãªã³ãåã çæããã å®æœäŸ ïŒ (S)âNâ²âïŒïŒâã€ãœãããã«ã¢ããâïŒâãã
ããã·ãããã«ïŒâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âïŒâããªããã³ãããã¯ã
ãªãåæ°Žåç© N2äžãNaHïŒ722mgã0.018ã¢ã«ïŒãDMSOïŒ150
mlïŒäžã®ïŒâããããã·âïŒâã¡ãã«âïŒâïŒïœ
âã¡ããã·ããšãã«ïŒããªããžã³ïŒ3.5ïœã0.016
ã¢ã«ïŒã®æº¶æ¶²ã«æ·»å ããæ··å液ã60âã§0.5æé
æ¹æãããDMSOïŒ150mlïŒäž(S)âïŒâïŒïŒâãã
ãã«ïŒâïŒâããããã·ã¡ãã«ãªããµãŸãªãâïŒ
âãªã³ã¡ã·ã¬ãŒãïŒ3.95ïœã0.016ã¢ã«ïŒã®æº¶æ¶²
ã滎å ããæ··å液ã60âã§äžæ©æ¹æããã次ã«å
å¿æ··å液ã宀枩ã«å·åŽããæ°Žã«æ³šå ¥ããCHCl3ã§
æœåºãããåãããææ©å±€ãæ°Žããã³NaCl飜å
溶液ã§æŽæµãã也ç¥ïŒNa2SO4ïŒãéããã³èž
çºä¹Ÿåºãããæ®æž£ãéæµäžç¡æ°Žãšã¿ããŒã«ïŒ180
mlïŒããã³10ïŒ NaOHïŒ180mlïŒãšïŒæéå ç±ãã
宀枩ã«å·åŽããH2Oã«æ³šå ¥ããŠCHCl3ã§æœåºã
ããåãããææ©å±€ãH2Oããã³NaCl飜å溶液
ã§æŽæµãã也ç¥ïŒNa2SO4ïŒããŠèžçºä¹Ÿåºããã
æ®æž£ã溶é¢æ¶²ãšããŠïŒïŒ CH3OHâCHCl3ã§ã·ãª
ã«ã²ã«äžã¯ãããã°ã©ãã€åŠçãããåŸãããé
é¢å¡©åºã6Nã»HClâãšã¿ããŒã«æº¶æ¶²ïŒ2.1mlïŒã§
åŠçããŠå¡©é žå¡©ã«è»¢åãããå¡©ãïŒâãããããŒ
ã«ã§åçµæ¶ããŠãçæç©780mgïŒ13ïŒ ïŒãçæãã
C18H25N3O3HClã»1/2H2OãšããŠè£æ£ããŠåæã
ããæ§é ã¯360MHzHNMRããã³ 13Cåå åæã«
ãã€ãŠç¢ºèªããã å®æœäŸïŒã«èšèŒãããéãïŒâã¡ãã«âïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒããªããžã³âïŒâãªã³
ã®ä»£ãã«ïŒâã¡ãã«âïŒâããšãã«ããªããžã³â
ïŒâãªã³ãçšããŠ(S)âNâ²âïŒïŒâã€ãœãããã«ã¢
ããâïŒâããããã·ãããã«ïŒâïŒâã¡ãã«â
ïŒâããšãã«ããªããžã³âïŒâãªã³ãçæããã å®æœäŸ ïŒ (S)âïŒâã¯ããâïŒâãïŒâïŒïŒïŒïŒâãžã¡ãã
ã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·ã
ãããã·ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âã¡ãã«ããªããžã³ 段éïŒïŒïŒïŒâãžã¯ããâïŒâã¡ãã«âïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒããªããžã³ã®
補é ïŒâã¯ããâïŒâããããã·âïŒâïŒïŒâã¡ã
ãã·ããšãã«ïŒâïŒâã¡ãã«ããªããžã³ïŒ1.0ïœã
0.004ã¢ã«ïŒããã³POCl3ïŒïŒmlïŒã®æ··å液ãN2äž
éæµäžã§ïŒæéå ç±ãã次ã«ïŒâã§16æéæŸçœ®ã
ããæ°·ãæ·»å ããPHã10ïŒ NaOHã§å¡©åºæ§ã«ã
ãã溶液ãCH2Cl2ã§æœåºãããåãããææ©å±€
ãæ°Žã§æŽæµãã也ç¥ïŒNa2SO4ïŒãéããã³èž
çºä¹Ÿåºãããæ®æž£ããšãã«ã¢ã»ããŒãâãããµã³
ã§åçµæ¶ããŠçæç©710mgïŒ66ïŒ ïŒãåŸããæ§é
ãMSããã³90MHz 1HNMRã«ãã€ãŠç¢ºèªããã 段éïŒ(S)âïŒâã¯ããâïŒâãïŒâïŒïŒïŒïŒâãž
ã¡ããã·ããšãã«ãšãã«ã¢ããïŒâïŒâ
ããããã·ããããã·ãâïŒâïŒïŒâã¡ã
ãã·ããšãã«ïŒâïŒâã¡ãã«ããªããžã³
ã®è£œé N2äžãNaHïŒ120mgã0.003ã¢ã«ïŒãDMFïŒ15
mlïŒäžã®ïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«ãšã
ã«ïŒâïŒâããããã·ã¡ãã«âïŒâããšãã«ãªã
ãµãŸãªãžã³ïŒ1.03ïœã0.003ã¢ã«ïŒã®æº¶æ¶²ã«æ·»å
ããæ··å液ã60âã§0.5æéæ¹æããã枩床ã25
âã«äœäžãããDMFïŒ15mlïŒäžæ®µéããã®çæ
ç©ïŒ690mgã0.003ã¢ã«ïŒã®æº¶æ¶²ãæ·»å ããã溶液
ã60âã§äžæ©æ¹æãããåå¿æ··å液ã宀枩ã«å·åŽ
ããDMFãæžå§äžã§é€å»ãããæ®æž£ãæ°Žããã³
CH2Cl2ã«åé ãããå¡©åºæ§æ°Žå±€ãCH2Cl2ã§æœåº
ãããåãããææ©å±€ãæ°Žã§æŽæµãã也ç¥
ïŒNa2SO2ïŒãéããã³èžçºä¹Ÿåºããã æ®æž£ã溶é¢æ¶²ãšããŠïŒïŒ ïŒâãããããŒã«â
CH2Cl2ãçšããŠã·ãªã«ã²ã«äžã¯ããã°ã©ãã€åŠ
çããCH3CNã§ïŒååçµæ¶ããŠçæç©ãm.p.94
ã95âã50mgïŒïŒïŒ ïŒãåŸãC25H30N3O5Clãšã
ãŠè£æ£ããŠåæãããæ§é ã360MHzã®HNMR
ã«ãã€ãŠç¢ºèªããã å®æœäŸïŒã«èšèŒãããéããïŒâã¯ããâïŒâ
ïŒïœâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«ããªããžã³
âïŒâãªã³ã®ä»£ããã«ïŒâã¡ãã«âïŒâããšãã«
ããªããžã³âïŒâãªã³ããã³ïŒïŒïŒâãžããšãã«
ããªããžã³âïŒâãªã³ãçšããŠåã ïŒâã¯ããâ
ïŒâã¡ãã«âïŒâããšãã«ããªããžã³ããã³ïŒâ
ã¯ããâïŒïŒïŒâãžããšãã«ããªããžã³ãåŸãã å®æœäŸïŒã«èšèŒãããéããïŒïŒïŒâãžã¯ãã
âïŒâã¡ãã«âïŒâïŒïœâã¡ããã·ããšãã«ïŒã
ãªããžã³ã®ä»£ããã«ïŒâã¯ããâïŒâã¡ãã«âïŒ
âããšãã«ããªããžã³ããã³ïŒâã¯ããâïŒïŒïŒ
âãžããšãã«ããªããžã³ãçšããŠã(S)âïŒâã¯ã
ãâïŒâãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«ãšã
ã«ïŒã¢ããâïŒâããããã·ããããã·ãïŒâã¡
ãã«âïŒâããšãã«ããªããžã³ããã³(S)âïŒâã¯
ããâïŒâãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«ãš
ãã«ïŒã¢ããâïŒâããããã·ããããã·ãâïŒïŒ
ïŒâãžããšãã«ããªããžã³ãçæããã é©åœãªåºçºç©è³ªãçšããå®è³ªçã«å®æœäŸïŒïŒïŒ
ãŸãã¯ïŒã«èšèŒãããæäœã䜿çšããŠã次ã®åå
ç©ãçæããã
ãè¡šã
ãè¡šã
é©åœãªåºçºç©è³ªãçšããŠå®æœäŸïŒã®æäœã䜿çš
ããŠæ¬¡ã®ååç©ãçæããã
ããŠæ¬¡ã®ååç©ãçæããã
ãè¡šã
ãè¡šã
å®æœäŸ ïŒ
é å€åŠæ¹
æ å éïŒmgïŒ
(S)âïŒâã¯ããâNâ²âïœïŒïŒïŒâãžã¡ããã·ã
ãšãã«ãšãã«ã¢ããïŒâïŒâããããã·ããã
ã«ïœâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ã
ã«âïŒâããªããã³ãããã¯ããªã 40.0 ãªã³é žã«ã«ã·ãŠã 120.0 ã©ã¯ããŒã¹ 50.0 ã§ãã·ã 23.5 ã¹ãã¢ãªã³é žãã°ãã·ãŠã 1.5 å®æœäŸ ïŒ ã«ãã»ã«åŠæ¹ æ å éïŒmgïŒ (S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«
ãšãã«ã¢ããïŒâïŒâããããã·ãããã«ãâïŒ
âïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«âïŒâ
ããªããã³ãããã¯ããªãã»ãã¹æ°Žåç© 250 ã©ã¯ããŒã¹ïŒU.S.P. 93 ã¿ã«ã¯ ïŒ å®æœäŸ ïŒ çŒåŠæ¹ æ å éïŒmgïŒ (S)âNâ²âïŒïŒâã€ãœãããã«ã¢ããâïŒâãã
ããã·ãããã«ïŒâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âïŒâããªããã³ãããã¯ã
ãªãåæ°Žåç© 15.0 äžå¡©åºæ§ãªã³é žãããªãŠã ã2H2O 6.10 äºå¡©åºæ§ãªã³é žãããªãŠã ã12H2O 16.80 å¡©åãã³ã¶ã«ã³ããŠã 0.10 æ°Žé žåãããªãŠã é©é PH6.8 泚å°çšæ°Ž é©é å šé 1.0ml å®æœäŸ ïŒ æ¶²äœæžæ¿æ¶² æ å éïŒmgïŒ (S)âïŒâã¯ããâïŒâãïŒâïŒïŒïŒïŒâãžã¡ãã
ã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·ã
ãããã·ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âã¡ãã«ããªããžã³ 5.0 ããŒãŽã H.V.ïŒVeegumH.V.ïŒ 3.0 ã¡ãã«ãã©ãã«ïŒmethyl parableïŒ 1.0 ã«ãªãªã³ 10.0 ã°ãªã»ãªã³ 250.0 æ°Ž é©éãïŒ
ãšãã«ãšãã«ã¢ããïŒâïŒâããããã·ããã
ã«ïœâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ã
ã«âïŒâããªããã³ãããã¯ããªã 40.0 ãªã³é žã«ã«ã·ãŠã 120.0 ã©ã¯ããŒã¹ 50.0 ã§ãã·ã 23.5 ã¹ãã¢ãªã³é žãã°ãã·ãŠã 1.5 å®æœäŸ ïŒ ã«ãã»ã«åŠæ¹ æ å éïŒmgïŒ (S)âNâ²âãïŒâïŒïŒïŒïŒâãžã¡ããã·ããšãã«
ãšãã«ã¢ããïŒâïŒâããããã·ãããã«ãâïŒ
âïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡ãã«âïŒâ
ããªããã³ãããã¯ããªãã»ãã¹æ°Žåç© 250 ã©ã¯ããŒã¹ïŒU.S.P. 93 ã¿ã«ã¯ ïŒ å®æœäŸ ïŒ çŒåŠæ¹ æ å éïŒmgïŒ (S)âNâ²âïŒïŒâã€ãœãããã«ã¢ããâïŒâãã
ããã·ãããã«ïŒâïŒâïŒïŒâã¡ããã·ããšã
ã«ïŒâïŒâã¡ãã«âïŒâããªããã³ãããã¯ã
ãªãåæ°Žåç© 15.0 äžå¡©åºæ§ãªã³é žãããªãŠã ã2H2O 6.10 äºå¡©åºæ§ãªã³é žãããªãŠã ã12H2O 16.80 å¡©åãã³ã¶ã«ã³ããŠã 0.10 æ°Žé žåãããªãŠã é©é PH6.8 泚å°çšæ°Ž é©é å šé 1.0ml å®æœäŸ ïŒ æ¶²äœæžæ¿æ¶² æ å éïŒmgïŒ (S)âïŒâã¯ããâïŒâãïŒâïŒïŒïŒïŒâãžã¡ãã
ã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·ã
ãããã·ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒ
âã¡ãã«ããªããžã³ 5.0 ããŒãŽã H.V.ïŒVeegumH.V.ïŒ 3.0 ã¡ãã«ãã©ãã«ïŒmethyl parableïŒ 1.0 ã«ãªãªã³ 10.0 ã°ãªã»ãªã³ 250.0 æ°Ž é©éãïŒ
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ§é åŒïŒ ãæããååç©ãŸãã¯ãã®å»è¬çã«äœ¿çšãåŸãå¡©
ãåŒäž R1ããã³R2ã¯ç¬ç«ã« ïŒ æ°ŽçŽ ã ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã ïŒ çœ®æãããªããŸãã¯ ïœ ããã ïœ C1-3ã¢ã«ã³ãã·ãŸãã¯ ïœ C1-3ã¢ã«ãã« ããéžæãããïŒãïŒåã®çœ®æåºã§çœ®æããã
ççŽ ç°ã¢ãªãŒã«ã ïŒ ïŒãŸãã¯ïŒå¡ã®è€çŽ ç°ã¢ãªãŒã«ïŒå°ãªããšã
ïŒå¡ãççŽ ååã§ãããããååã¯ïŒ¯ïŒïŒ®ãŸã
ã¯ïŒ³ã§ãããïŒã§ããã R3ã¯ïŒ æ°ŽçŽ ã ïŒ ããã ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã§ã
ãã R4ã¯ïŒ çŽéãŸãã¯åæéã®C1-8ãã¢ã«ãã«ã ïŒ C3-6ã·ã¯ãã¢ã«ãã«ã ïŒ ã¢ãªãŒã«âC1-4ã¢ã«ãã«ïŒC1-4ã¢ã«ã
ã«éšåã¯çŽéãŸãã¯åæéã§ãããã¢ãª
ãŒã«éšåã¯ããšãã«ãŸãã¯ãããã«ã§ã
ã€ãŠçœ®æãããªãããŸãã¯ïŒãŸãã¯ïŒå
ã®çœ®æåºã§çœ®æããããïŒã§ããããã ïŒ çŸ€ïŒ (S)âïŒâã¯ããâNâ²âãïŒâïŒïŒïŒïŒâãžã¡ã
ãã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·ã
ããã«ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡
ãã«âïŒâããªããã³ã(S)âNâ²âãïŒâïŒïŒïŒïŒ
âãžã¡ããã·ããšãã«ãšãã«ã¢ããïŒâïŒâãã
ããã·ãããã«ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâã¡ãã«âïŒâããªããã³ããŸã㯠(S)âNâ²âïŒïŒâã€ãœãããã«ã¢ããâïŒâãã
ããã·ãããã«ïŒâïŒâïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâã¡ãã«âïŒâããªããã³ ã®äžå¡ãŸãã¯ãã®å»è¬çã«äœ¿çšãåŸãå¡©ã§ããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ æ§é åŒïŒ ãæããååç©ãŸãã¯ãã®å»è¬çã«äœ¿çšãåŸãå¡©
ãåŒäž R1ããã³R2ã¯ç¬ç«ã« ïŒ æ°ŽçŽ ã ïŒ çŽéãŸãã¯åæéã®C1-8ã¢ã«ãã«ã ïŒ çœ®æãããªããŸãã¯ ïœ ããã ïœ C1-3ã¢ã«ã³ãã·ãŸãã¯ ïœ C1-3ã¢ã«ãã« ããéžæãããïŒãïŒåã®çœ®æåºã§çœ®æããã
ççŽ ç°ã¢ãªãŒã«ã ïŒ ïŒãŸãã¯ïŒå¡ã®è€çŽ ç°ã¢ãªãŒã«ïŒå°ãªããšã
ïŒå¡ãççŽ ååã§ãããããååã¯ïŒ¯ïŒïŒ®ãŸã
ã¯ïŒ³ã§ãããïŒã§ããã R3ã¯ïŒ æ°ŽçŽ ã ïŒ ããã ïŒ çŽéãŸãã¯åæéã®C1-H8ã¢ã«ãã«ã§
ããã R4ã¯ïŒ çŽéãŸãã¯åæéã®C1-8ãã¢ã«ãã«ã ïŒ C3-6ã·ã¯ãã¢ã«ãã«ã ïŒ ã¢ãªãŒã«âC1-4ã¢ã«ãã«ïŒC1-4ã¢ã«ã
ã«éšåã¯çŽéãŸãã¯åæéã§ãããã¢ãª
ãŒã«éšåã¯ããšãã«ãŸãã¯ãããã«ã§ã
ã€ãŠçœ®æãããªãããŸãã¯ïŒãŸãã¯ïŒå
ã®çœ®æåºã§çœ®æããããïŒã§ããããã®è£œ
é æ³ã§ãã€ãŠãäžèšåŒ ãåŒäžR5ã¢ãªãŒã«ãŸãã¯C1-4ã¢ã«ãã«ãŸã
ã¯ïŒïŒ¯ã§ãããR4ã¯äžã§å®çŸ©ããéãã§ã
ããããæããååç©ãR5ãã¢ãªãŒã«ãŸãã¯
C1-4ã¢ã«ãã«ã®å Žåã¯é žã§ããŸãã¯R5ãïŒïŒ
ã®å Žåã¯å¡©åºã§åŠçããããšãç¹åŸŽãšãã補é
æ¹æ³ã ïŒ çŸ€ïŒ (S)âïŒâã¯ããâNâ²âãïŒâïŒïŒïŒïŒâãžã¡ã
ãã·ããšãã«ãšãã«ã¢ããïŒâïŒâããããã·ã
ããã«ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒâïŒâã¡
ãã«âïŒâããªããã³ã(S)âNâ²âãïŒâïŒïŒïŒïŒ
âãžã¡ããã·ããšãã«ãšãã«ã¢ããïŒâïŒâãã
ããã·ãããã«ãâïŒâïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâã¡ãã«âïŒâããªããã³ããŸã㯠(S)âNâ²âïŒïŒâã€ãœãããã«ã¢ããâïŒâãã
ããã·ãããã«ïŒâïŒâïŒïŒâã¡ããã·ããšãã«ïŒ
âïŒâã¡ãã«âïŒâããªããã³ ã®ååç©ãŸãã¯ãã®å»è¬çã«äœ¿çšãåŸãå¡©ã補é
ããããã®ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US585739 | 1984-03-02 | ||
US06/585,739 US4598149A (en) | 1984-03-02 | 1984-03-02 | 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60208967A JPS60208967A (ja) | 1985-10-21 |
JPH0524900B2 true JPH0524900B2 (ja) | 1993-04-09 |
Family
ID=24342754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60038943A Granted JPS60208967A (ja) | 1984-03-02 | 1985-03-01 | ããªããžã³âïŒâãªã³ã®ïŒâã¢ããâïŒâããããã·ãããã«èªå°äœ |
Country Status (5)
Country | Link |
---|---|
US (1) | US4598149A (ja) |
EP (1) | EP0153746B1 (ja) |
JP (1) | JPS60208967A (ja) |
DE (1) | DE3580598D1 (ja) |
ZA (1) | ZA851568B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4764427B2 (ja) | 2004-09-08 | 2011-09-07 | ã¬ãã·ã§ãŠ ãããªã㯠ãªãããã ã«ã³ãã㌠| æ€åºè£ 眮ããã³æ¹æ³ |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57108073A (en) * | 1980-11-11 | 1982-07-05 | Nattermann A & Cie | N-substituted omega-(2-oxo-4-imidazoline- 1-yl)alkanoic acid compound |
JPS5951269A (ja) * | 1982-07-29 | 1984-03-24 | ã¢âã»ããã¿âãã³ã»ãŠã³ãã»ã·âã»ã²ãŒã«ã·ã€ããã»ãããã»ãã·ãŠã¬ã³ã¯ãã«ã»ãããã³ã° | ããªããšãã«ã€ãããŸãªã«ãªãã·ã¢ã«ã«ã³é žããã³ãã®èªå°äœ |
JPS59181265A (ja) * | 1983-03-25 | 1984-10-15 | Fujisawa Pharmaceut Co Ltd | ããªããžã³èªå°äœ |
JPS59206364A (ja) * | 1983-05-09 | 1984-11-22 | ããªã¹ãã«âãã€ã€ãŒãºãã¹ã¯ã€ããã«ã³ãã㌠| ïŒâããªããžãã«ãªãã·âïŒâãããã¢ãªâã«ã¢ã«ãã«ã¢ããâïŒâããããâã«ããã³ãã®è£œæ³ãšçšé |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042586A (en) * | 1972-05-05 | 1977-08-16 | Merck Sharp & Dohme (I.A.) Corporation | 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines |
US3946009A (en) * | 1972-05-05 | 1976-03-23 | Merck Sharp & Dohme (I.A.) Corporation | 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines |
US4410530A (en) * | 1973-02-20 | 1983-10-18 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines |
US4115575A (en) * | 1973-02-20 | 1978-09-19 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-pyrazines |
AR208397A1 (es) * | 1973-02-20 | 1976-12-27 | Ciba Geigy Ag | Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan |
US4195090A (en) * | 1973-02-20 | 1980-03-25 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith |
CH592625A5 (ja) * | 1974-05-14 | 1977-10-31 | Ciba Geigy Ag | |
US4612376A (en) * | 1983-03-25 | 1986-09-16 | Fujisawa Pharmaceutical Co., Ltd. | Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent |
-
1984
- 1984-03-02 US US06/585,739 patent/US4598149A/en not_active Expired - Fee Related
-
1985
- 1985-02-28 EP EP85102224A patent/EP0153746B1/en not_active Expired - Lifetime
- 1985-02-28 DE DE8585102224T patent/DE3580598D1/de not_active Expired - Fee Related
- 1985-03-01 JP JP60038943A patent/JPS60208967A/ja active Granted
- 1985-08-01 ZA ZA851568A patent/ZA851568B/xx unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57108073A (en) * | 1980-11-11 | 1982-07-05 | Nattermann A & Cie | N-substituted omega-(2-oxo-4-imidazoline- 1-yl)alkanoic acid compound |
JPS5951269A (ja) * | 1982-07-29 | 1984-03-24 | ã¢âã»ããã¿âãã³ã»ãŠã³ãã»ã·âã»ã²ãŒã«ã·ã€ããã»ãããã»ãã·ãŠã¬ã³ã¯ãã«ã»ãããã³ã° | ããªããšãã«ã€ãããŸãªã«ãªãã·ã¢ã«ã«ã³é žããã³ãã®èªå°äœ |
JPS59181265A (ja) * | 1983-03-25 | 1984-10-15 | Fujisawa Pharmaceut Co Ltd | ããªããžã³èªå°äœ |
JPS59206364A (ja) * | 1983-05-09 | 1984-11-22 | ããªã¹ãã«âãã€ã€ãŒãºãã¹ã¯ã€ããã«ã³ãã㌠| ïŒâããªããžãã«ãªãã·âïŒâãããã¢ãªâã«ã¢ã«ãã«ã¢ããâïŒâããããâã«ããã³ãã®è£œæ³ãšçšé |
Also Published As
Publication number | Publication date |
---|---|
US4598149A (en) | 1986-07-01 |
JPS60208967A (ja) | 1985-10-21 |
EP0153746B1 (en) | 1990-11-22 |
EP0153746A3 (en) | 1986-06-11 |
DE3580598D1 (de) | 1991-01-03 |
ZA851568B (en) | 1985-10-30 |
EP0153746A2 (en) | 1985-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4139535A (en) | 3-Cyano-2-pyridinyloxymethyl-oxazolidine derivatives | |
DE69200378T2 (de) | Indolderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel. | |
US4374841A (en) | Pyridoxine derivatives, and use in therapeutics | |
US4166851A (en) | Certain imidazo(1,2a)pyridine derivatives | |
US4673675A (en) | 1-(2-pyridyl) 4-cycloalkylmethyl piperazines having cardiotropic activity | |
JP3939246B2 (ja) | ã€ã³ãããããŸãªãã³é¡ | |
EP0112142B1 (en) | Pyridine derivatives | |
US4408047A (en) | Imidazodiazines | |
DE4330959A1 (de) | Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung | |
JP2840288B2 (ja) | 眮æïŒâïŒïŒïœâã€ãããŸãŒã«âïŒâã€ã«ïŒã¢ã«ãã«âãã³ãºã¢ãã | |
CH632495A5 (de) | Verfahren zur herstellung neuer substituierter pyridine. | |
EP0038784B1 (en) | 3,8-dialkylxanthines, processes for their preparation and compositions containing them | |
US4158013A (en) | N-Cyano-N'-alkynyl-N"-2-mercaptoethylguanidines | |
US4153797A (en) | α-Aryl-α, α-bis[Ï- (disubstituted amino)alkyl]acetamides and related compounds | |
US4157340A (en) | N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives | |
JPH0524900B2 (ja) | ||
US4562184A (en) | Substituted-aminohydroxypropoxy-thiadiazoles, β-blocking compositions and use | |
US4233301A (en) | Novel imidazoazines and imidazodiazines | |
US4564621A (en) | α-Aryl-α-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same | |
US4593039A (en) | 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols | |
US4330543A (en) | Imidazoazines and imidazodiazines | |
JPH0115506B2 (ja) | ||
JPS62135461A (ja) | æ°èŠïŒïŒïŒââãâïŒïœâã€ãããŸâã«é¡ | |
PL91401B1 (ja) | ||
DE3434271A1 (de) | Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |